[{"id":"e62ad255-a0aa-442f-b7a2-df8080edb58d","acronym":"","url":"https://clinicaltrials.gov/study/NCT03065010","created_at":"2021-01-18T15:05:50.117Z","updated_at":"2024-07-02T16:37:13.067Z","phase":"Phase 1a/1b","brief_title":"Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer","source_id_and_acronym":"NCT03065010","lead_sponsor":"Biocad","biomarkers":" HER-2 • ER","pipe":" | ","alterations":" ER positive • HER-2 negative","tags":["HER-2 • ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER positive • HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Senexin B"],"overall_status":"Completed","enrollment":" Enrollment 6","initiation":"Initiation: 11/01/2016","start_date":" 11/01/2016","primary_txt":" Primary completion: 03/01/2018","primary_completion_date":" 03/01/2018","study_txt":" Completion: 03/01/2018","study_completion_date":" 03/01/2018","last_update_posted":"2018-03-13"}]